Skip to main content
Top
Published in: Endocrine 2/2020

01-02-2020 | Foreign Body Aspiration | Original Article

A randomized trial comparing health-related quality-of-life and utility measures between routine fine-needle aspiration cytology (FNAC) and surveillance alone in patients with thyroid incidentaloma measuring 1–2 cm

Authors: Carlos K. H. Wong, Brian H. H. Lang

Published in: Endocrine | Issue 2/2020

Login to get access

Abstract

Purpose

To present the impact of treatment on health-related quality-of-life (HRQOL) and health utility measures from the randomized controlled trial (ClinicalTrials.gov Identifier: NCT02398721) that investigated the FNAC versus watchful surveillance in patients with incidental benign thyroid nodules.

Methods

Health utility and HRQOL were evaluated using the EQ-5D 5-level (EQ-5D-5L), 6-item Short-Form Health Survey (SF-6D), and generic 12-item Short-Form Health Survey (SF-12v2) at baseline, 3-month, 6-month, and 12-month assessments. A repeated measure analysis of variance evaluated differences in HRQOL scores between treatment groups over time. Multiple imputations were used to impute missing data at each time point.

Results

HRQOL data completion rates were 99.7% at baseline, 92.7% at 3-month, 93.9% at 6-month, 92.7% at 12-month, and 88.6% at 18-month follow-up after baseline. There were significant mean differences in SF-6D, EQ-5D-5L, and SF-12v2 over time except the domain of vitality and mental health of SF-12v2. Mean change of SF-12v2 scores and utility scores from baseline between groups did not exceed minimal important difference. No significant treatment group by time interactions were found in all HRQOL and utility scores except in the vitality domain and PCS of SF-12v2 (p value = 0.033; 0.024).

Conclusions

When compared with watchful surveillance, FNAC intervention was associated with better vitality and physical-related HRQOL scores but did not provide better preservation of utility score improvement over the 18-month period. These findings support the routine FNAC approach for nodules that have a low-suspicion sonographic pattern and measure between 1.0 and 2.0 cm.
Appendix
Available only for authorised users
Literature
1.
go back to reference S. Ezzat et al. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch. Intern. Med. 154(16), 1838–1840 (1994)CrossRef S. Ezzat et al. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch. Intern. Med. 154(16), 1838–1840 (1994)CrossRef
2.
go back to reference D.S. Dean, H. Gharib, Epidemiology of thyroid nodules. Best. Pract. Res. Clin. Endocrinol. Metab. 22(6), 901–911 (2008)CrossRef D.S. Dean, H. Gharib, Epidemiology of thyroid nodules. Best. Pract. Res. Clin. Endocrinol. Metab. 22(6), 901–911 (2008)CrossRef
3.
go back to reference D.S. Ross, Nonpalpable thyroid nodules–managing an epidemic. J. Clin. Endocrinol. Metab. 87(5), 1938–1940 (2002)PubMed D.S. Ross, Nonpalpable thyroid nodules–managing an epidemic. J. Clin. Endocrinol. Metab. 87(5), 1938–1940 (2002)PubMed
4.
go back to reference G. Russ, Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 35(1), 25–38 (2016)CrossRef G. Russ, Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 35(1), 25–38 (2016)CrossRef
5.
go back to reference S. Leboulleux et al. Frequency and intensity of pain related to thyroid nodule fine-needle aspiration cytology. Thyroid 23(9), 1113–1118 (2013)CrossRef S. Leboulleux et al. Frequency and intensity of pain related to thyroid nodule fine-needle aspiration cytology. Thyroid 23(9), 1113–1118 (2013)CrossRef
6.
go back to reference B.R. Haugen et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRef B.R. Haugen et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRef
7.
go back to reference L. Lodewijk et al. Same-day fine-needle aspiration cytology diagnosis for thyroid nodules achieves rapid anxiety decrease and high diagnostic accuracy. Endocr. Pract. 22(5), 561–566 (2016)CrossRef L. Lodewijk et al. Same-day fine-needle aspiration cytology diagnosis for thyroid nodules achieves rapid anxiety decrease and high diagnostic accuracy. Endocr. Pract. 22(5), 561–566 (2016)CrossRef
8.
go back to reference C.K.H. Wong et al. EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: acceptability and psychometric evaluation. Patient 10(4), 447–454 (2017)CrossRef C.K.H. Wong et al. EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: acceptability and psychometric evaluation. Patient 10(4), 447–454 (2017)CrossRef
9.
go back to reference P. Wang et al. The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value Health Reg. Issues 9, 57–62 (2016)CrossRef P. Wang et al. The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value Health Reg. Issues 9, 57–62 (2016)CrossRef
10.
go back to reference P.W.H. Cheung et al. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord. 11, 19 (2016)CrossRef P.W.H. Cheung et al. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord. 11, 19 (2016)CrossRef
11.
go back to reference C.-W. Pan et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med. Decis. Mak. 36(2), 234–241 (2016)CrossRef C.-W. Pan et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med. Decis. Mak. 36(2), 234–241 (2016)CrossRef
12.
go back to reference B. van Hout et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15(5), 708–715 (2012)CrossRef B. van Hout et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15(5), 708–715 (2012)CrossRef
13.
go back to reference G.G. Liu et al. Chinese time trade-off values for EQ-5D health states. Value Health 17(5), 597–604 (2014)CrossRef G.G. Liu et al. Chinese time trade-off values for EQ-5D health states. Value Health 17(5), 597–604 (2014)CrossRef
14.
go back to reference N.S. McClure et al. Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores. Value Health 20(4), 644–650 (2017)CrossRef N.S. McClure et al. Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores. Value Health 20(4), 644–650 (2017)CrossRef
15.
go back to reference J.E. Brazier, J. Roberts, The estimation of a preference-based measure of health from the SF-12. Med. Care 42(9), 851–859 (2004)CrossRef J.E. Brazier, J. Roberts, The estimation of a preference-based measure of health from the SF-12. Med. Care 42(9), 851–859 (2004)CrossRef
16.
go back to reference C.L.K. Lam, J. Brazier, S.M. McGhee, Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a chinese population. Value Health 11(2), 295–303 (2008)CrossRef C.L.K. Lam, J. Brazier, S.M. McGhee, Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a chinese population. Value Health 11(2), 295–303 (2008)CrossRef
17.
go back to reference S.M. McGhee et al. Quality-adjusted life years: population-specific measurement of the quality component. Hong. Kong Med. J. 17(Suppl 6), 17–21 (2011)PubMed S.M. McGhee et al. Quality-adjusted life years: population-specific measurement of the quality component. Hong. Kong Med. J. 17(Suppl 6), 17–21 (2011)PubMed
18.
go back to reference S.J. Walters, J.E. Brazier, Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual. Life Res. 14(6), 1523–1532 (2005)CrossRef S.J. Walters, J.E. Brazier, Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual. Life Res. 14(6), 1523–1532 (2005)CrossRef
19.
go back to reference C.K. Wong, E.T. Lam, C.L. Lam, Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients. Qual. Life Res. 22(10), 2973–2981 (2013)CrossRef C.K. Wong, E.T. Lam, C.L. Lam, Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients. Qual. Life Res. 22(10), 2973–2981 (2013)CrossRef
Metadata
Title
A randomized trial comparing health-related quality-of-life and utility measures between routine fine-needle aspiration cytology (FNAC) and surveillance alone in patients with thyroid incidentaloma measuring 1–2 cm
Authors
Carlos K. H. Wong
Brian H. H. Lang
Publication date
01-02-2020
Publisher
Springer US
Published in
Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02129-y

Other articles of this Issue 2/2020

Endocrine 2/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.